Hepatology, 1527-3350

Journal

More filtering options
  1. 1993
  2. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg

    Zhang, Y-Y., Hansson, B-G., Kuo, L. S., Anders Widell & Nordenfelt, E., 1993, In : Hepatology. 17, 4, p. 538-544

    Research output: Contribution to journalArticle

  3. 1994
  4. Laser-induced Ala Photodynamic Therapy In the Treatment of Rat-liver Tumor

    Liu, D. L., Katarina Svanberg, Wang, I., Andersson-Engels, S., Stenram, U. & Sune Svanberg, 1994, In : Hepatology. 20, 4

    Research output: Contribution to journalArticle

  5. 1997
  6. 2001
  7. Impact of selective inactivation of transforming growth factor-beta type II receptor gene (TGFBR2) during viral hepatitis

    Lemmer, E. R., Conner, E. A., Leveen, P., Factor, V. M., Tsai, T. L., Huh, C. G., Stefan Karlsson & Thorgeirsson, S. S., 2001, In : Hepatology. 34, 4, Suppl. 2, p. 491A-491A

    Research output: Contribution to journalArticle

  8. 2003
  9. Absence of Helicobacter species in the liver of patients with primary or metastatic liver cancer.

    Wadström, T., Abu Al-Soud, W., Ljungh, Å., Nilsson, H-O. & Stenram, U., 2003, In : Hepatology. 38, 2, p. 532-533

    Research output: Contribution to journalLetter

  10. 2004
  11. Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha(1)-antitrypsin.

    Sabina Janciauskiene, Eriksson, S., Callea, F., Mallya, M., Zhou, A., Seyarna, K., Hata, S. & Lomas, D. A., 2004, In : Hepatology. 40, 5, p. 1203-1210

    Research output: Contribution to journalArticle

  12. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice

    Oe, S., Lemmer, ER., Conner, EA., Factor, VM., Levéen, P., Jonas Larsson, Stefan Karlsson & Thorgeirsson, SS., 2004, In : Hepatology. 40, 5, p. 1098-1105

    Research output: Contribution to journalArticle

  13. 2005
  14. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

    Simmonds, P., Bukh, J., Combet, C., Deleage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspe, G., Kuiken, C., Maertens, G., Mizokami, M., Murphy, D. G., Okamoto, H., Pawlotsky, J. M., Penin, F. O., Sablon, E., Tadasu, S. I., Stuyver, L., Thiel, H. J., Viazov, S. & 2 others, Weiner, A. & Anders Widell, 2005, In : Hepatology. 42, 4, p. 962-973

    Research output: Contribution to journalArticle

  15. 2006
  16. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation

    Hanne Prytz, Keiding, S., Bjornsson, E., Broome, U., Ahner, S., Castedal, M. & Munk, O. L., 2006, In : Hepatology. 44, 6, p. 1572-1580

    Research output: Contribution to journalArticle

  17. 2008
  18. IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS

    Dalgard, O., Verbaan, H., Ring-Larsen, H. & Bjoro, K., 2008, In : Hepatology. 48, 4, p. 1875

    Research output: Contribution to journalPublished meeting abstract

Previous 1 2 3 Next